Mice with GPR65 KO tumors had a higher tumor burden in all organs examined than mice with m.CR tumors (Fig. 3E; Supplementary Fig. S3E), and this was associated with increased tumor-associated morbidities and diminished survival. Here, GPR65 is linked to neoplasm.